Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.0234.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.99% | -30.10% | 12.25% | -2.25% | -146.61% |
| Total Depreciation and Amortization | 6.99% | 7.52% | -0.70% | -1.18% | 15.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.29% | 13.20% | 18.46% | 24.20% | 108.24% |
| Change in Net Operating Assets | 184.19% | 114.06% | -2.75% | -369.91% | 188.96% |
| Cash from Operations | 138.71% | 66.23% | 11.59% | -528.96% | 76.13% |
| Capital Expenditure | 68.06% | -273.05% | 27.04% | -112.95% | -62.78% |
| Sale of Property, Plant, and Equipment | 10.53% | 13.10% | -15.15% | -5.71% | 600.00% |
| Cash Acquisitions | -- | -- | -- | -- | 53.80% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 71.78% | -318.54% | 28.78% | 70.86% | 50.32% |
| Total Debt Issued | -1.59% | -21.60% | 12.07% | 32.51% | 21.00% |
| Total Debt Repaid | -0.12% | 3.93% | -10.86% | -11.42% | -10.59% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 26.88% | -- | 100.00% | 88.03% | -19.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205.85% | 443.58% | 58.94% | -82.43% | -336.63% |
| Cash from Financing | -116.07% | -17.41% | 24.23% | 1,493.54% | -97.47% |
| Foreign Exchange rate Adjustments | -619.05% | 275.00% | 75.51% | -163.64% | 245.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.79% | 88.29% | 165.74% | 54.03% | -165.71% |
